Veru (VERU) Non-Current Deferred Revenue (2009 - 2014)
Veru (VERU) recorded Non-Current Deferred Revenue of $39,196 in fiscal Q3 2014 (quarter ended Jun 30, 2014), down 38.8% from $64,027 a year earlier and down 13.7% from the prior quarter.
Powered by 
Analysis
Veru (VERU) Non-Current Deferred Revenue (2009 - 2014) Analysis & Trends
At the end of FY2013 (ended Sep 30, 2013), Veru reported Non-Current Deferred Revenue of $57,819, down 30.0% from FY2012.
- Annual Non-Current Deferred Revenue has declined for three straight fiscal years, with a three-year compound annual growth rate of -24.1% (FY2010 to FY2013).
- Across earlier fiscal years, Non-Current Deferred Revenue came in at $82,650 in FY2012 (-23.1%), $107,481 in FY2011 (-18.8%) and $132,312 in FY2010.
- The fiscal Q3 2014 figure is the lowest quarterly Non-Current Deferred Revenue in data going back to fiscal Q4 2010.
- On a year-over-year basis, Non-Current Deferred Revenue has declined for nine consecutive quarters, with an average decline of 29.8% over the last eight quarters.
- Across the past five years, year-over-year decline in Non-Current Deferred Revenue ran from 18.8% in fiscal Q4 2011 to 38.8% in fiscal Q3 2014.
- Per Business Quant, the preceding three fiscal quarters came in at $45,403 (Q2 2014), $51,611 (Q1 2014) and $57,819 (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Veru | 48.87 Mn | -61.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2014 | 39,196.00 |
| Mar 31, 2014 | 45,403.00 |
| Dec 31, 2013 | 51,611.00 |
| Sep 30, 2013 | 57,819.00 |
| Jun 30, 2013 | 64,027.00 |
| Mar 31, 2013 | 70,234.00 |
| Dec 31, 2012 | 76,442.00 |
| Sep 30, 2012 | 82,650.00 |
| Jun 30, 2012 | 88,858.00 |
| Mar 31, 2012 | 95,065.00 |
| Dec 31, 2011 | 101,273.00 |
| Sep 30, 2011 | 107,481.00 |
| Jun 30, 2011 | 113,689.00 |
| Mar 31, 2011 | 119,896.00 |
| Dec 31, 2010 | 126,104.00 |
| Sep 30, 2010 | 132,312.00 |
| Jun 30, 2010 | 138,520.00 |
| Mar 31, 2010 | 144,727.00 |
| Dec 31, 2009 | 150,935.00 |
| Sep 30, 2009 | 157,143.00 |
API Access
Veru Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();